APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vascular Graft

Vascular grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vascular grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.

Selected research

Market Outlook & Growth Opportunities

Global Vascular Graft Market Outlook and Growth Opportunities 2026

25 December 2025194 pages

Choose your research edition.

Industry ResearchVascular Graft Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Graft Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Vascular Graft Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Graft Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Graft Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Vascular grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.

At present, in developed countries, the vascular graft industry is generally at a more advanced level. The world's large enterprises are mainly concentrated in North America. The top three manufacturers are Getinge Group, Bard, Terumo, respectively with global production market share as 15%, 13% and 12%.

The global largest market is North America. The consumption volume share is 41%, and the secondary market is EU, the consumption volume share is 30%.

Read the full market overview

There are major three classification of vascular graft in this report, the ePTFE vascular graft, polyester vascular graft and PTFE vascular graft. Globally, the production share of each type of vascular graft is 25%, 20%and 16%.

This report provides an overview of the global Vascular Graft market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vascular Graft and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vascular Graft sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vascular Graft market size, projected growth trends, production technologies, key applications, and end-use industries.

Vascular Graft Segment by Company

Getinge Group

Bard

Terumo

W. L. Gore

JUNKEN MEDICAL

B.Braun

LeMaitre

Shanghai Suokang

Shanghai Chest Medical

Vascular Graft Segment by Type

ePTFE Vascular Graft

Polyester Vascular Graft

PTFE Vascular Graft

Others

Vascular Graft Segment by Application

Cardiovascular Diseases

Aneurysm

Vascular Occlusion

Others

Vascular Graft Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vascular Graft status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vascular Graft market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vascular Graft significant trends, drivers, influence factors in global and regions.

6. To analyze Vascular Graft competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Graft market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Graft and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Graft.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vascular Graft market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vascular Graft industry.

Chapter 3: Detailed analysis of Vascular Graft manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vascular Graft in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vascular Graft in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vascular Graft Industry Trends Table 2. Vascular Graft Industry Drivers Table 3. Vascular Graft Industry Opportunities and Challenges Table 4. Vascular Graft Industry Restraints Table 5. Global Vascular Graft Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vascular Graft Revenue Share by Company (2021-2026) Table 7. Global Vascular Graft Sales Volume by Company (Pcs) & (2021-2026) Table 8. Global Vascular Graft Sales Volume Share by Company (2021-2026) Table 9. Global Vascular Graft Average Price (USD/Pcs) of Company (2021-2026) Table 10. Global Vascular Graft Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vascular Graft Key Company Manufacturing Base & Headquarters Table 12. Global Vascular Graft Company, Product Type & Application Table 13. Global Vascular Graft Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vascular Graft by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ePTFE Vascular Graft Table 18. Significant Companies of Polyester Vascular Graft Table 19. Significant Companies of PTFE Vascular Graft Table 20. Significant Companies of Others Table 21. Global Vascular Graft Sales Volume by Type 2021 VS 2025 VS 2032 (Pcs) Table 22. Global Vascular Graft Sales Volume by Type (2021-2026) & (Pcs) Table 23. Global Vascular Graft Sales Volume by Type (2027-2032) & (Pcs) Table 24. Global Vascular Graft Sales Volume Share by Type (2021-2026) Table 25. Global Vascular Graft Sales Volume Share by Type (2027-2032) Table 26. Global Vascular Graft Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Vascular Graft Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Vascular Graft Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Vascular Graft Sales Value Share by Type (2021-2026) Table 30. Global Vascular Graft Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Cardiovascular Diseases Table 32. Significant Companies of Aneurysm Table 33. Significant Companies of Vascular Occlusion Table 34. Significant Companies of Others Table 35. Global Vascular Graft Sales Volume by Application 2021 VS 2025 VS 2032 (Pcs) Table 36. Global Vascular Graft Sales Volume by Application (2021-2026) & (Pcs) Table 37. Global Vascular Graft Sales Volume by Application (2027-2032) & (Pcs) Table 38. Global Vascular Graft Sales Volume Share by Application (2021-2026) Table 39. Global Vascular Graft Sales Volume Share by Application (2027-2032) Table 40. Global Vascular Graft Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Vascular Graft Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Vascular Graft Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Vascular Graft Sales Value Share by Application (2021-2026) Table 44. Global Vascular Graft Sales Value Share by Application (2027-2032) Table 45. Global Vascular Graft Sales by Region: 2021 VS 2025 VS 2032 (Pcs) Table 46. Global Vascular Graft Sales by Region (2021-2026) & (Pcs) Table 47. Global Vascular Graft Sales Market Share by Region (2021-2026) Table 48. Global Vascular Graft Sales by Region (2027-2032) & (Pcs) Table 49. Global Vascular Graft Sales Market Share by Region (2027-2032) Table 50. Global Vascular Graft Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Vascular Graft Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Vascular Graft Sales Value Share by Region (2021-2026) Table 53. Global Vascular Graft Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Vascular Graft Sales Value Share by Region (2027-2032) Table 55. Global Vascular Graft Market Average Price (USD/Pcs) by Region (2021-2026) Table 56. Global Vascular Graft Market Average Price (USD/Pcs) by Region (2027-2032) Table 57. Global Vascular Graft Sales by Country: 2021 VS 2025 VS 2032 (Pcs) Table 58. Global Vascular Graft Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Vascular Graft Sales by Country (2021-2026) & (Pcs) Table 60. Global Vascular Graft Sales Market Share by Country (2021-2026) Table 61. Global Vascular Graft Sales by Country (2027-2032) & (Pcs) Table 62. Global Vascular Graft Sales Market Share by Country (2027-2032) Table 63. Global Vascular Graft Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Vascular Graft Sales Value Market Share by Country (2021-2026) Table 65. Global Vascular Graft Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Vascular Graft Sales Value Market Share by Country (2027-2032) Table 67. Getinge Group Company Information Table 68. Getinge Group Business Overview Table 69. Getinge Group Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 70. Getinge Group Vascular Graft Product Portfolio Table 71. Getinge Group Recent Development Table 72. Bard Company Information Table 73. Bard Business Overview Table 74. Bard Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 75. Bard Vascular Graft Product Portfolio Table 76. Bard Recent Development Table 77. Terumo Company Information Table 78. Terumo Business Overview Table 79. Terumo Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 80. Terumo Vascular Graft Product Portfolio Table 81. Terumo Recent Development Table 82. W. L. Gore Company Information Table 83. W. L. Gore Business Overview Table 84. W. L. Gore Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 85. W. L. Gore Vascular Graft Product Portfolio Table 86. W. L. Gore Recent Development Table 87. JUNKEN MEDICAL Company Information Table 88. JUNKEN MEDICAL Business Overview Table 89. JUNKEN MEDICAL Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 90. JUNKEN MEDICAL Vascular Graft Product Portfolio Table 91. JUNKEN MEDICAL Recent Development Table 92. B.Braun Company Information Table 93. B.Braun Business Overview Table 94. B.Braun Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 95. B.Braun Vascular Graft Product Portfolio Table 96. B.Braun Recent Development Table 97. LeMaitre Company Information Table 98. LeMaitre Business Overview Table 99. LeMaitre Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 100. LeMaitre Vascular Graft Product Portfolio Table 101. LeMaitre Recent Development Table 102. Shanghai Suokang Company Information Table 103. Shanghai Suokang Business Overview Table 104. Shanghai Suokang Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 105. Shanghai Suokang Vascular Graft Product Portfolio Table 106. Shanghai Suokang Recent Development Table 107. Shanghai Chest Medical Company Information Table 108. Shanghai Chest Medical Business Overview Table 109. Shanghai Chest Medical Vascular Graft Sales (Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 110. Shanghai Chest Medical Vascular Graft Product Portfolio Table 111. Shanghai Chest Medical Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Vascular Graft Distributors List Table 115. Vascular Graft Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Vascular Graft Product Image Figure 2. Global Vascular Graft Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vascular Graft Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vascular Graft Sales (2021-2032) & (Pcs) Figure 5. Global Vascular Graft Sales Average Price (USD/Pcs) & (2021-2032) Figure 6. Global Vascular Graft Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ePTFE Vascular Graft Image Figure 10. Polyester Vascular Graft Image Figure 11. PTFE Vascular Graft Image Figure 12. Others Image Figure 13. Global Vascular Graft Sales Volume by Type (2021 VS 2025 VS 2032) & (Pcs) Figure 14. Global Vascular Graft Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Vascular Graft Sales Volume Share by Type (2021-2032) Figure 16. Global Vascular Graft Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Vascular Graft Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Vascular Graft Sales Value Share by Type (2021-2032) Figure 19. Cardiovascular Diseases Image Figure 20. Aneurysm Image Figure 21. Vascular Occlusion Image Figure 22. Others Image Figure 23. Global Vascular Graft Sales Volume by Application (2021 VS 2025 VS 2032) & (Pcs) Figure 24. Global Vascular Graft Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Vascular Graft Sales Volume Share by Application (2021-2032) Figure 26. Global Vascular Graft Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Vascular Graft Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Vascular Graft Sales Value Share by Application (2021-2032) Figure 29. Global Vascular Graft Sales by Region: 2021 VS 2025 VS 2032 (Pcs) Figure 30. Global Vascular Graft Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Vascular Graft Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Vascular Graft Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Vascular Graft Sales Value (2021-2032) & (US$ Million) Figure 34. North America Vascular Graft Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Vascular Graft Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Vascular Graft Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Vascular Graft Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Vascular Graft Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Vascular Graft Sales Value (2021-2032) & (US$ Million) Figure 40. South America Vascular Graft Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Vascular Graft Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Vascular Graft Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Vascular Graft Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Vascular Graft Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Vascular Graft Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Vascular Graft Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Vascular Graft Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • ePTFE Vascular Graft
  • Polyester Vascular Graft
  • PTFE Vascular Graft
  • Others
Applications
  • Cardiovascular Diseases
  • Aneurysm
  • Vascular Occlusion
  • Others
Companies covered
  • Getinge Group
  • Bard
  • Terumo
  • W. L. Gore
  • JUNKEN MEDICAL
  • B.Braun
  • LeMaitre
  • Shanghai Suokang
  • Shanghai Chest Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vascular Graft Sales Value (2021-2032)
  4. 1.2.2 Global Vascular Graft Sales Volume (2021-2032)
  5. 1.2.3 Global Vascular Graft Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vascular Graft Market Dynamics
  1. 2.1 Vascular Graft Industry Trends
  2. 2.2 Vascular Graft Industry Drivers
  3. 2.3 Vascular Graft Industry Opportunities and Challenges
  4. 2.4 Vascular Graft Industry Restraints
3 Vascular Graft Market by Company
  1. 3.1 Global Vascular Graft Company Revenue Ranking in 2025
  2. 3.2 Global Vascular Graft Revenue by Company (2021-2026)
  3. 3.3 Global Vascular Graft Sales Volume by Company (2021-2026)
  4. 3.4 Global Vascular Graft Average Price by Company (2021-2026)
  5. 3.5 Global Vascular Graft Company Ranking (2024-2026)
  6. 3.6 Global Vascular Graft Company Manufacturing Base and Headquarters
  7. 3.7 Global Vascular Graft Company Product Type and Application
  8. 3.8 Global Vascular Graft Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vascular Graft Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vascular Graft Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vascular Graft Market by Type
  1. 4.1 Vascular Graft Type Introduction
  2. 4.1.1 ePTFE Vascular Graft
  3. 4.1.2 Polyester Vascular Graft
  4. 4.1.3 PTFE Vascular Graft
  5. 4.1.4 Others
  6. 4.2 Global Vascular Graft Sales Volume by Type
  7. 4.2.1 Global Vascular Graft Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Vascular Graft Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Vascular Graft Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Vascular Graft Sales Value by Type
  11. 4.3.1 Global Vascular Graft Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Vascular Graft Sales Value by Type (2021-2032)
  13. 4.3.3 Global Vascular Graft Sales Value Share by Type (2021-2032)
5 Vascular Graft Market by Application
  1. 5.1 Vascular Graft Application Introduction
  2. 5.1.1 Cardiovascular Diseases
  3. 5.1.2 Aneurysm
  4. 5.1.3 Vascular Occlusion
  5. 5.1.4 Others
  6. 5.2 Global Vascular Graft Sales Volume by Application
  7. 5.2.1 Global Vascular Graft Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Vascular Graft Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Vascular Graft Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Vascular Graft Sales Value by Application
  11. 5.3.1 Global Vascular Graft Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Vascular Graft Sales Value by Application (2021-2032)
  13. 5.3.3 Global Vascular Graft Sales Value Share by Application (2021-2032)
6 Vascular Graft Regional Sales and Value Analysis
  1. 6.1 Global Vascular Graft Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vascular Graft Sales by Region (2021-2032)
  3. 6.2.1 Global Vascular Graft Sales by Region: 2021-2026
  4. 6.2.2 Global Vascular Graft Sales by Region (2027-2032)
  5. 6.3 Global Vascular Graft Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vascular Graft Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vascular Graft Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vascular Graft Sales Value by Region (2027-2032)
  9. 6.5 Global Vascular Graft Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vascular Graft Sales Value (2021-2032)
  12. 6.6.2 North America Vascular Graft Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vascular Graft Sales Value (2021-2032)
  15. 6.7.2 Europe Vascular Graft Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vascular Graft Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vascular Graft Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vascular Graft Sales Value (2021-2032)
  21. 6.9.2 South America Vascular Graft Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vascular Graft Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vascular Graft Sales Value Share by Country, 2025 VS 2032
7 Vascular Graft Country-level Sales and Value Analysis
  1. 7.1 Global Vascular Graft Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vascular Graft Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vascular Graft Sales by Country (2021-2032)
  4. 7.3.1 Global Vascular Graft Sales by Country (2021-2026)
  5. 7.3.2 Global Vascular Graft Sales by Country (2027-2032)
  6. 7.4 Global Vascular Graft Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vascular Graft Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vascular Graft Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vascular Graft Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vascular Graft Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vascular Graft Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vascular Graft Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vascular Graft Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vascular Graft Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vascular Graft Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vascular Graft Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vascular Graft Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vascular Graft Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vascular Graft Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vascular Graft Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vascular Graft Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vascular Graft Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vascular Graft Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vascular Graft Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vascular Graft Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vascular Graft Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vascular Graft Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vascular Graft Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vascular Graft Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vascular Graft Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vascular Graft Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vascular Graft Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vascular Graft Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vascular Graft Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vascular Graft Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vascular Graft Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vascular Graft Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vascular Graft Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vascular Graft Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vascular Graft Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vascular Graft Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vascular Graft Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vascular Graft Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vascular Graft Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vascular Graft Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vascular Graft Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vascular Graft Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vascular Graft Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vascular Graft Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vascular Graft Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vascular Graft Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vascular Graft Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vascular Graft Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vascular Graft Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vascular Graft Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vascular Graft Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vascular Graft Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vascular Graft Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vascular Graft Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vascular Graft Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vascular Graft Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vascular Graft Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vascular Graft Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vascular Graft Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vascular Graft Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vascular Graft Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vascular Graft Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vascular Graft Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vascular Graft Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vascular Graft Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vascular Graft Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vascular Graft Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vascular Graft Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vascular Graft Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vascular Graft Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vascular Graft Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vascular Graft Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vascular Graft Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vascular Graft Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vascular Graft Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vascular Graft Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vascular Graft Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vascular Graft Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vascular Graft Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vascular Graft Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vascular Graft Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vascular Graft Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vascular Graft Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vascular Graft Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vascular Graft Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vascular Graft Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vascular Graft Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Getinge Group
  2. 8.1.1 Getinge Group Company Information
  3. 8.1.2 Getinge Group Business Overview
  4. 8.1.3 Getinge Group Vascular Graft Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Getinge Group Vascular Graft Product Portfolio
  6. 8.1.5 Getinge Group Recent Developments
  7. 8.2 Bard
  8. 8.2.1 Bard Company Information
  9. 8.2.2 Bard Business Overview
  10. 8.2.3 Bard Vascular Graft Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bard Vascular Graft Product Portfolio
  12. 8.2.5 Bard Recent Developments
  13. 8.3 Terumo
  14. 8.3.1 Terumo Company Information
  15. 8.3.2 Terumo Business Overview
  16. 8.3.3 Terumo Vascular Graft Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Vascular Graft Product Portfolio
  18. 8.3.5 Terumo Recent Developments
  19. 8.4 W. L. Gore
  20. 8.4.1 W. L. Gore Company Information
  21. 8.4.2 W. L. Gore Business Overview
  22. 8.4.3 W. L. Gore Vascular Graft Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 W. L. Gore Vascular Graft Product Portfolio
  24. 8.4.5 W. L. Gore Recent Developments
  25. 8.5 JUNKEN MEDICAL
  26. 8.5.1 JUNKEN MEDICAL Company Information
  27. 8.5.2 JUNKEN MEDICAL Business Overview
  28. 8.5.3 JUNKEN MEDICAL Vascular Graft Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 JUNKEN MEDICAL Vascular Graft Product Portfolio
  30. 8.5.5 JUNKEN MEDICAL Recent Developments
  31. 8.6 B.Braun
  32. 8.6.1 B.Braun Company Information
  33. 8.6.2 B.Braun Business Overview
  34. 8.6.3 B.Braun Vascular Graft Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 B.Braun Vascular Graft Product Portfolio
  36. 8.6.5 B.Braun Recent Developments
  37. 8.7 LeMaitre
  38. 8.7.1 LeMaitre Company Information
  39. 8.7.2 LeMaitre Business Overview
  40. 8.7.3 LeMaitre Vascular Graft Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LeMaitre Vascular Graft Product Portfolio
  42. 8.7.5 LeMaitre Recent Developments
  43. 8.8 Shanghai Suokang
  44. 8.8.1 Shanghai Suokang Company Information
  45. 8.8.2 Shanghai Suokang Business Overview
  46. 8.8.3 Shanghai Suokang Vascular Graft Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Suokang Vascular Graft Product Portfolio
  48. 8.8.5 Shanghai Suokang Recent Developments
  49. 8.9 Shanghai Chest Medical
  50. 8.9.1 Shanghai Chest Medical Company Information
  51. 8.9.2 Shanghai Chest Medical Business Overview
  52. 8.9.3 Shanghai Chest Medical Vascular Graft Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai Chest Medical Vascular Graft Product Portfolio
  54. 8.9.5 Shanghai Chest Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vascular Graft Value Chain Analysis
  2. 9.1.1 Vascular Graft Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vascular Graft Sales Mode & Process
  6. 9.2 Vascular Graft Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vascular Graft Distributors
  9. 9.2.3 Vascular Graft Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst